These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 16182820

  • 21. [Mortality in pediatric renal transplants: 15 years' experience].
    Harzallah K, Floret D, Martin X, Cochat P.
    Arch Pediatr; 2004 Aug; 11(8):916-20. PubMed ID: 15288081
    [Abstract] [Full Text] [Related]

  • 22. [Infectious complications in 159 consecutive kidney transplant recipients].
    García-Prado ME, Cordero E, Cabello V, Pereira P, Torrubia FJ, Ruíz M, Cisneros JM.
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):22-7. PubMed ID: 19217999
    [Abstract] [Full Text] [Related]

  • 23. Polyomavirus-associated nephropathy in simultaneous kidney-pancreas transplant recipients: a single-center experience.
    Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Freise CE.
    Transplant Proc; 2004 May; 36(4):1097-8. PubMed ID: 15194382
    [Abstract] [Full Text] [Related]

  • 24. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D, Chen JH, Wu WZ, Yang SL, Wu GJ, Wang H, Tan JM.
    Transplant Proc; 2007 May; 39(1):69-72. PubMed ID: 17275476
    [Abstract] [Full Text] [Related]

  • 25. Cytomegalovirus infection in renal transplant recipients.
    Carstens J, Andersen HK, Spencer E, Madsen M.
    Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
    [Abstract] [Full Text] [Related]

  • 26. Cytomegalovirus infections in cardiac transplant patients: an experience at a clinical hospital, university of Chile.
    Sepulveda L, Llancaqueo M, Zamorano J, Bermudez C, Cortes C.
    Transplant Proc; 2007 Apr; 39(3):622-4. PubMed ID: 17445560
    [Abstract] [Full Text] [Related]

  • 27. Renal transplant and cytomegalovirus infection: experience in a community hospital program.
    Matulis WS, Cokeley G, Matulis M, Funk E.
    W V Med J; 1992 Oct; 88(10):454-6. PubMed ID: 1333681
    [Abstract] [Full Text] [Related]

  • 28. [Descriptive study of infectious complications in 109 consecutive liver transplant recipients].
    García-Prado E, Cordero E, Alamo JM, Gómez MA, Pascasio JM, Sánchez M, Cisneros JM.
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):199-205. PubMed ID: 19361893
    [Abstract] [Full Text] [Related]

  • 29. Influence of cytomegalovirus disease on early and late renal graft function.
    Boratyńska M, Banasik M, Watorek E, Patrzałek D, Szyber P, Klinger M.
    Transplant Proc; 2006 Apr; 38(1):147-50. PubMed ID: 16504688
    [Abstract] [Full Text] [Related]

  • 30. Infectious complications following 72 consecutive enteric-drained pancreas transplants.
    Berger N, Wirmsberger R, Kafka R, Margreiter C, Ebenbichler C, Stelzmueller I, Margreiter R, Steurer W, Mark W, Bonatti H.
    Transpl Int; 2006 Jul; 19(7):549-57. PubMed ID: 16764633
    [Abstract] [Full Text] [Related]

  • 31. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [Abstract] [Full Text] [Related]

  • 32. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
    Sevmis S, Emiroglu R, Karakayali F, Yagmurdur MC, Dalgic A, Moray G, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
    [Abstract] [Full Text] [Related]

  • 33. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V.
    Transplantation; 2009 Feb 15; 87(3):436-44. PubMed ID: 19202451
    [Abstract] [Full Text] [Related]

  • 34. The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients.
    Ozdemir FN, Akgul A, Altunoglu A, Bilgic A, Arat Z, Haberal M.
    Transplant Proc; 2007 May 15; 39(4):990-2. PubMed ID: 17524871
    [Abstract] [Full Text] [Related]

  • 35. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH, Mao YY, He Q, Wu JY, Lv R.
    Transplant Proc; 2005 Dec 15; 37(10):4203-7. PubMed ID: 16387078
    [Abstract] [Full Text] [Related]

  • 36. Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients.
    Haririan A, Morawski K, West MS, El-Amm JM, Doshi MD, Cincotta E, Alangaden GJ, Chandrasekar P, Gruber SA.
    Clin Transplant; 2007 Dec 15; 21(4):466-71. PubMed ID: 17645705
    [Abstract] [Full Text] [Related]

  • 37. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
    Wang D, Wu WZ, Yang SL, Chen JH, Tan JM.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1683-8. PubMed ID: 17097014
    [Abstract] [Full Text] [Related]

  • 38. Oral ulcers during the course of cytomegalovirus infection in renal transplant recipients.
    López-Pintor RM, Hernández G, de Arriba L, Morales JM, Jiménez C, de Andrés A.
    Transplant Proc; 2009 Oct 20; 41(6):2419-21. PubMed ID: 19715938
    [Abstract] [Full Text] [Related]

  • 39. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR.
    Transplant Proc; 2008 Oct 20; 40(1):137-9. PubMed ID: 18261569
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.